Lifitegrast Efficacy and Safety in Phase 3 Trials
Brandon Ayres, MD, provides an overview of lifitegrast efficacy and safety from the OPUS trials for the treatment of dry eye disease.
EP: 1.Dry Eye Disease Overview
EP: 2.Prevalence and Risk Factors of Dry Eye Disease
EP: 3.Pathophysiology of Dry Eye Disease
EP: 4.Initiating Dry Eye Treatment
EP: 5.Dry Eye Disease Diagnosis
EP: 6.MGD Diagnosis
EP: 7.Treatment Approaches to Dry Eye Disease
EP: 8.Anti-inflammatory Agents in Dry Eye Disease
EP: 9.Lifitegrast Mechanism of Action
Now Viewing
EP: 10.Lifitegrast Efficacy and Safety in Phase 3 Trials
EP: 11.Dry Eye Disease: OPUS Trials
EP: 12.Choosing a Treatment for Dry Eye Disease
EP: 13.Procedural Therapies for Dry Eye Disease
EP: 14.Managing Dry Eye Disease Before Cataract and Refractive Surgery
EP: 15.Dry Eye Disease: Patients With Contacts
EP: 16.Emerging Treatments for Dry Eye Disease
Related Videos
Related Content
